Avrio makes second investment after previously providing an undisclosed amount to Biopharmacopae's series A round in December 2008.
Avrio Ventures, a Canada-based venture capital firm formed in 2006 by local companies Farm Credit Canada and Kirchner Investment Management, has invested C$2m ($2m) in Biopharmacopae Design International, a drug developer based on using plant-derived ingredients.
Avrio previously provided an undisclosed amount to Biopharmacopae’s series A round in December 2008.
The money will help commercialise Biopharmacopae’s Ridovir Cold product.
Aki Georgacacos, a partner at Avrio, said: "Biopharmacopae holds a portfolio of extremely promising products with significant market potential and…
